Nyxoah SA (NYXH) vs Pro-Dex, Inc. (PDEX)
Nyxoah SA and Pro-Dex, Inc. are both Medical Instruments & Supplies companies. Pro-Dex, Inc. is the larger, with a market value of $233.9M against $129.3M — 1.8× the size. Nyxoah SA has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 17.0×. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 16.5%. Pro-Dex, Inc. has the higher net margin (17.6% vs −446.4%) and the higher return on invested capital (15.8% vs −117.8%). Across the 19 metrics below, Pro-Dex, Inc. leads on 13 and Nyxoah SA on 6.
Valuation
Profitability
| Metric | NYXH | PDEX | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.16% | 31.38% | 54.62% |
| Operating margin | (391.25%) | 16.75% | 1.64% |
| Net margin | (446.39%) | 17.62% | 0.00% |
| Free cash flow margin | (344.99%) | 8.72% | 1.61% |
| Return on equity | (124.41%) | 32.43% | 0.00% |
| Return on assets | (68.23%) | 20.14% | 0.00% |
| Return on invested capital | (117.82%) | 15.75% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack